Imaflex Third Quarter 2022 Earnings: EPS: CA$0.06 (vs CA$0.055 in 3Q 2021)

Imaflex (CVE:IFX) Third Quarter 2022 Results

Key Financial Results

• Revenue: CA$26.6m (down 9.8% from 3Q 2021).

• Net income: CA$3.12m (up 13% from 3Q 2021).

• Profit margin: 12% (up from 9.4% in 3Q 2021). The increase in margin was driven by lower expenses.

• EPS: CA$0.06 (up from CA$0.055 in 3Q 2021).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Imaflex Earnings Insights

Looking ahead, revenue is forecast to grow 6.2% p.a. on average during the next 2 years, compared to a 3.9% growth forecast for the Packaging industry in Canada.

Performance of the Canadian Packaging industry.

The company's shares are down 2.0% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Imaflex, and understanding this should be part of your investment process.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here